GlassScriptPhysician profile
Katherine Machado
NPI 1275950511
$2,864.19
in general payments reported to CMS, 2019-2025
19 companies · $557 in 2025
The $557 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $60.99 · 2021: $188 · 2022: $482 · 2023: $504 · 2024: $950 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,429 · Travel and Lodging: $525 · Debt Forgiveness: $45.96 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,428.53 |
| Travel and Lodging | $525.18 |
| Debt Forgiveness | $45.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,105.95 | 2019-2025 | |
| Smith+Nephew, INC. | $499.79 | 2020-2025 | Collagenase Santyl, Grafix Pl, Stravix |
| Abbvie INC. | $392.64 | 2021-2023 | |
| Paratek Pharmaceuticals, INC. | $127.51 | 2023-2025 | Nuzyra |
| Innovation Technologies INC | $112.99 | 2023 | Irrisept |
| Organogenesis INC. | $108.21 | 2020-2024 | Puraply Am |
| Medtronic, INC. | $87.87 | 2024-2025 | Intellis Adaptivestim |
| Hnm Stainless, LLC | $87.50 | 2024 | |
| Djo, LLC | $59.53 | 2025 | Cmf |
| Stryker Corporation | $51.32 | 2025 | Asnis, Ortholoc Sps |
| Kerecis Limited | $43.07 | 2019-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Melinta Therapeutics, LLC | $39.35 | 2022-2023 | Orbactiv, Kimyrsa |
| Reprise Biomedical, INC. | $31.86 | 2024 | Miro3d |
| Amgen INC. | $31.18 | 2025 | Krystexxa |
| Biotissue Holdings INC. | $27.45 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $21.40 | 2024 | |
| Nabriva Therapeutics, Plc | $19.16 | 2022 | |
| Kci USA, INC. | $11.98 | 2020 | |
| Saluda Medical Americas, INC. | $5.43 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Machado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.